LT3074033T - Junginiai, skirti nutukimo gydymui ir jų panaudojimo būdai - Google Patents
Junginiai, skirti nutukimo gydymui ir jų panaudojimo būdaiInfo
- Publication number
- LT3074033T LT3074033T LTEP14816018.7T LT14816018T LT3074033T LT 3074033 T LT3074033 T LT 3074033T LT 14816018 T LT14816018 T LT 14816018T LT 3074033 T LT3074033 T LT 3074033T
- Authority
- LT
- Lithuania
- Prior art keywords
- obesity
- compounds
- treatment
- methods
- Prior art date
Links
- 208000008589 Obesity Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 235000020824 obesity Nutrition 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2264—Obesity-gene products, e.g. leptin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361908998P | 2013-11-26 | 2013-11-26 | |
| PCT/US2014/067393 WO2015081093A1 (en) | 2013-11-26 | 2014-11-25 | Compounds for the treatment of obesity and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT3074033T true LT3074033T (lt) | 2019-02-25 |
Family
ID=52134396
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEP14816018.7T LT3074033T (lt) | 2013-11-26 | 2014-11-25 | Junginiai, skirti nutukimo gydymui ir jų panaudojimo būdai |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20160375039A1 (lt) |
| EP (1) | EP3074033B1 (lt) |
| JP (2) | JP6672157B2 (lt) |
| AU (2) | AU2014354831B2 (lt) |
| CA (1) | CA2931826C (lt) |
| CY (1) | CY1122551T1 (lt) |
| DK (1) | DK3074033T3 (lt) |
| ES (1) | ES2709976T3 (lt) |
| HR (1) | HRP20190219T1 (lt) |
| HU (1) | HUE042196T2 (lt) |
| LT (1) | LT3074033T (lt) |
| PL (1) | PL3074033T3 (lt) |
| PT (1) | PT3074033T (lt) |
| RS (1) | RS58422B1 (lt) |
| SI (1) | SI3074033T1 (lt) |
| SM (1) | SMT201900064T1 (lt) |
| TR (1) | TR201901299T4 (lt) |
| WO (1) | WO2015081093A1 (lt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015153933A1 (en) * | 2014-04-03 | 2015-10-08 | The Children's Medical Center Corporation | Hsp90 inhibitors for the treatment of obesity and methods of use thereof |
| CN106008657B (zh) * | 2016-05-20 | 2017-11-21 | 天津中医药大学 | 苦蘵苦素i及提取方法及用途 |
| IT201800005336A1 (it) * | 2018-05-14 | 2019-11-14 | Composizioni per uso nel trattamento dell’obesità | |
| WO2021072139A1 (en) * | 2019-10-11 | 2021-04-15 | Massachusetts Institute Of Technology | Formulations for gastrointestinal delivery of oligonucleotides |
| CN113599502A (zh) * | 2021-07-22 | 2021-11-05 | 廖儒佳 | 一种醉茄素a和瘦素的组合物及其在制备预防和或治疗出血性脑卒中药物中的应用 |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA791659B (en) | 1978-04-17 | 1980-04-30 | Ici Ltd | Process and apparatus for spraying liquid |
| GB8504253D0 (en) | 1985-02-19 | 1985-03-20 | Ici Plc | Electrostatic spraying apparatus |
| US4938763B1 (en) | 1988-10-03 | 1995-07-04 | Atrix Lab Inc | Biodegradable in-situ forming implants and method of producing the same |
| MY107937A (en) | 1990-02-13 | 1996-06-29 | Takeda Chemical Industries Ltd | Prolonged release microcapsules. |
| US6350730B1 (en) | 1994-08-17 | 2002-02-26 | The Rockefeller University | OB polypeptides and modified forms as modulators of body weight |
| US6001968A (en) | 1994-08-17 | 1999-12-14 | The Rockefeller University | OB polypeptides, modified forms and compositions |
| US6309853B1 (en) | 1994-08-17 | 2001-10-30 | The Rockfeller University | Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| US6429290B1 (en) | 1994-08-17 | 2002-08-06 | The Rockefeller University | OB polypeptides, modified forms and derivatives |
| US5827734A (en) | 1995-01-20 | 1998-10-27 | University Of Washington | Materials and methods for determining ob protein in a biological sample |
| US5521283A (en) | 1995-01-31 | 1996-05-28 | Eli Lilly And Company | Anti-obesity proteins |
| US5552524A (en) | 1995-01-31 | 1996-09-03 | Eli Lilly And Company | Anti-obesity proteins |
| US5552522A (en) | 1995-01-31 | 1996-09-03 | Eli Lilly And Company | Anti-obesity proteins |
| US5532336A (en) | 1995-01-31 | 1996-07-02 | Eli Lilly And Company | Anti-obesity proteins |
| US5552523A (en) | 1995-01-31 | 1996-09-03 | Eli Lilly And Company | Anti-obesity proteins |
| WO1996040912A1 (en) | 1995-06-07 | 1996-12-19 | Amgen Inc. | Ob protein compositions and method |
| PL324284A1 (en) | 1995-06-30 | 1998-05-11 | Lilly Co Eli | Methods of treating diabetes |
| ATE259650T1 (de) | 1995-08-17 | 2004-03-15 | Amgen Inc | Verfahren zur verringerung und zur erhaltung von verringerten blutspiegeln von lipiden mittels zubereitungen von ob-proteinen |
| US20030040467A1 (en) | 1998-06-15 | 2003-02-27 | Mary Ann Pelleymounter | Ig/ob fusions and uses thereof. |
| ATE259243T1 (de) | 1995-11-22 | 2004-02-15 | Amgen Inc | Fettleibigkeitsprotein (ob) zur erhögung der mageren körpermasse |
| US6936439B2 (en) | 1995-11-22 | 2005-08-30 | Amgen Inc. | OB fusion protein compositions and methods |
| AU2670897A (en) | 1996-04-04 | 1997-10-29 | Amgen, Inc. | Fibulin pharmaceutical compositions and related methods |
| JP2000514422A (ja) * | 1996-06-20 | 2000-10-31 | メルク エンド カンパニー インコーポレーテッド | 肥満のための遺伝子治療 |
| WO1998008512A1 (en) | 1996-08-30 | 1998-03-05 | Amgen Inc. | Methods of increasing sensitivity of an individual to ob protein by upregulating ob protein receptor |
| PL332458A1 (en) | 1996-09-20 | 1999-09-13 | Hoechst Ag | Application of leptin antagonists in treating insulin resistance in cases of diabeted of type ii |
| ES2221019T3 (es) | 1996-10-31 | 2004-12-16 | Takeda Chemical Industries, Ltd. | Preparacion de liberacion mantenida. |
| ES2280083T3 (es) | 1996-12-20 | 2007-09-01 | Amgen Inc. | Composiciones de proteinas de fusion ob y metodos. |
| AU7132798A (en) | 1997-04-17 | 1998-11-11 | Amgen, Inc. | Compositions comprising conjugates of stable, active, human ob protein with antibody fc chain and methods |
| HUP0003428A3 (en) | 1997-06-06 | 2001-12-28 | Smithkline Beecham Plc | Use of leptin antagonists for the treatment of diabetes |
| US7052678B2 (en) | 1997-09-15 | 2006-05-30 | Massachusetts Institute Of Technology | Particles for inhalation having sustained release properties |
| US6541033B1 (en) | 1998-06-30 | 2003-04-01 | Amgen Inc. | Thermosensitive biodegradable hydrogels for sustained delivery of leptin |
| AU5347099A (en) | 1998-08-10 | 2000-03-06 | Amgen, Inc. | Dextran-leptin conjugates, pharmaceutical compositions and related methods |
| CA2344623A1 (en) | 1998-10-02 | 2000-04-13 | Amgen Inc. | Method to determine a predisposition to leptin treatment |
| US6420339B1 (en) | 1998-10-14 | 2002-07-16 | Amgen Inc. | Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility |
| PT1151102E (pt) | 1999-02-12 | 2006-07-31 | Amgen Inc | Composicoes de leptina glicosilada e metodos afins |
| DK2219031T3 (da) | 2001-10-22 | 2013-06-17 | Amgen Inc | Anvendelse af leptin til behandling af human lipoatrofi og fremgangsmåde til bestemmelse af prædisposition for behandlinngen |
| WO2004039832A2 (en) | 2002-10-31 | 2004-05-13 | Albany Medical College | Leptin-related peptides |
| JP4585186B2 (ja) * | 2003-07-31 | 2010-11-24 | 杏林製薬株式会社 | 肥満、糖尿病及び脂質代謝異常の新規な予防又は治療剤 |
| JP2009541423A (ja) * | 2006-06-23 | 2009-11-26 | ラボラトリオス・デル・ドクトル・エステベ・ソシエダッド・アノニマ | コリンエステラーゼ阻害剤と５‐ｈｔ６レセプター親和性の化合物との組合せ |
| US20110230551A1 (en) * | 2008-09-15 | 2011-09-22 | Leslie Gunatilaka | Withaferin a analogs and uses thereof |
| WO2010053655A2 (en) * | 2008-11-07 | 2010-05-14 | University Of Kansas | Therapeutic methods with withaferin a and analogs |
| WO2012106393A2 (en) * | 2011-02-01 | 2012-08-09 | University Of Kansas | Withanolide isolated from physalis longifolia and analogs and methods of use thereof |
-
2014
- 2014-11-25 LT LTEP14816018.7T patent/LT3074033T/lt unknown
- 2014-11-25 EP EP14816018.7A patent/EP3074033B1/en active Active
- 2014-11-25 WO PCT/US2014/067393 patent/WO2015081093A1/en active Application Filing
- 2014-11-25 PL PL14816018T patent/PL3074033T3/pl unknown
- 2014-11-25 SM SM20190064T patent/SMT201900064T1/it unknown
- 2014-11-25 JP JP2016554826A patent/JP6672157B2/ja active Active
- 2014-11-25 ES ES14816018T patent/ES2709976T3/es active Active
- 2014-11-25 AU AU2014354831A patent/AU2014354831B2/en not_active Ceased
- 2014-11-25 DK DK14816018.7T patent/DK3074033T3/en active
- 2014-11-25 SI SI201431046T patent/SI3074033T1/sl unknown
- 2014-11-25 TR TR2019/01299T patent/TR201901299T4/tr unknown
- 2014-11-25 HU HUE14816018A patent/HUE042196T2/hu unknown
- 2014-11-25 US US15/039,743 patent/US20160375039A1/en not_active Abandoned
- 2014-11-25 RS RS20190124A patent/RS58422B1/sr unknown
- 2014-11-25 CA CA2931826A patent/CA2931826C/en active Active
- 2014-11-25 PT PT14816018T patent/PT3074033T/pt unknown
-
2018
- 2018-01-23 AU AU2018200517A patent/AU2018200517B2/en not_active Ceased
-
2019
- 2019-02-01 HR HRP20190219TT patent/HRP20190219T1/hr unknown
- 2019-02-05 CY CY20191100155T patent/CY1122551T1/el unknown
- 2019-12-16 JP JP2019226600A patent/JP2020059744A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| SMT201900064T1 (it) | 2019-02-28 |
| US20160375039A1 (en) | 2016-12-29 |
| AU2014354831B2 (en) | 2017-10-26 |
| TR201901299T4 (tr) | 2019-02-21 |
| JP6672157B2 (ja) | 2020-03-25 |
| RS58422B1 (sr) | 2019-04-30 |
| AU2014354831A1 (en) | 2016-06-09 |
| ES2709976T3 (es) | 2019-04-22 |
| JP2020059744A (ja) | 2020-04-16 |
| JP2016537431A (ja) | 2016-12-01 |
| CY1122551T1 (el) | 2021-01-27 |
| CA2931826A1 (en) | 2015-06-04 |
| WO2015081093A1 (en) | 2015-06-04 |
| EP3074033A1 (en) | 2016-10-05 |
| SI3074033T1 (sl) | 2019-03-29 |
| HRP20190219T1 (hr) | 2019-03-22 |
| EP3074033B1 (en) | 2018-11-07 |
| AU2018200517A1 (en) | 2018-02-15 |
| HUE042196T2 (hu) | 2019-06-28 |
| PL3074033T3 (pl) | 2019-08-30 |
| PT3074033T (pt) | 2019-02-08 |
| DK3074033T3 (en) | 2019-02-11 |
| CA2931826C (en) | 2021-11-16 |
| AU2018200517B2 (en) | 2019-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL273090B (en) | Methods and preparations for the treatment of cancer | |
| IL243976A0 (en) | kdm1a inhibitors for disease treatment | |
| HK1221408A1 (zh) | 用於治療成膠質細胞瘤的組合療法 | |
| GB201320729D0 (en) | Therapeutic compounds and their use | |
| HK1254296A1 (zh) | 治療性化合物和其用途 | |
| EP2970317A4 (en) | PYRIMIDODIAZEPINONE COMPOUNDS AND METHOD FOR THE TREATMENT OF DISEASES | |
| PL3021838T3 (pl) | Leczenie otyłości | |
| EP2968298A4 (en) | 2,4-THIAZOLIDINEDIONES ENRICHED IN DEUTERIUM AND METHODS OF TREATMENT | |
| HRP20181879T1 (hr) | Spojevi za liječenje pretilosti i postupci za njihovu upotrebu | |
| HK1217092A1 (zh) | 治療性化合物及其用途 | |
| HRP20190219T1 (hr) | Spojevi za tretman pretilosti i postupci za njihovu uporabu | |
| IL247325A0 (en) | Therapeutic methods using noribogaine and related compounds | |
| HK1220374A1 (zh) | 用於治療碳氧血紅蛋白血症的組合物和方法 | |
| GB201311361D0 (en) | Compounds and their therapeutic use | |
| GB201309375D0 (en) | Medical methods and compounds for medical use | |
| GB201308736D0 (en) | Compounds and their therapeutic use | |
| GB201308665D0 (en) | Device for the treatment of bone conditions | |
| AU2013900139A0 (en) | Device for the treatment of snoring | |
| GB201309379D0 (en) | Medical methods and compounds for medical use | |
| GB201309376D0 (en) | Medical methods and compounds for medical use | |
| GB201317804D0 (en) | Therapeutic compounds and their use | |
| GB201316173D0 (en) | Compounds and their therapeutic use | |
| GB201307677D0 (en) | Compounds and their therapeutic use |